Microbial marker in inflammatory arthritis diseases KU Leuven
The present invention relates to methods for detecting the presence or assessing the risk of development of inflammatory arthritis diseases, more particularly of joint and/or gut inflammation in patients with inflammatory arthritis diseases, even more particularly of joint and/or gut inflammation in patients with spondyloarthritis (SpA) based on gut microbial markers. Also encompassed are methods to assess disease activity in patients with an inflammatory arthritis disease using said markers.